Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,866 | -11,716 | -5,864 | -21,138 | -15,027 |
| Depreciation Amortization | 1,795 | 1,199 | 602 | 2,433 | 1,816 |
| Accounts payable and accrued liabilities | -592 | -212 | 99 | -78 | -853 |
| Other Working Capital | -306 | -79 | 15 | 508 | 604 |
| Other Operating Activity | 2,445 | 1,268 | 471 | 1,738 | 2,039 |
| Operating Cash Flow | $-14,524 | $-9,540 | $-4,677 | $-16,537 | $-11,421 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -198 | -37 | -6 | -122 | -114 |
| Investing Cash Flow | $-198 | $-37 | $-6 | $-122 | $-114 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,135 | 837 | 741 | 201 | 201 |
| Common Stock Repurchased | 37,487 | 37,497 | N/A | N/A | N/A |
| Other Financing Activity | 302 | 302 | 0 | 0 | 0 |
| Financing Cash Flow | $38,924 | $38,636 | $741 | $201 | $201 |
| Exchange Rate Effect | 313 | 39 | 138 | 513 | 415 |
| Beginning Cash Position | 15,823 | 15,823 | 15,823 | 31,768 | 31,768 |
| End Cash Position | 40,338 | 44,921 | 12,019 | 15,823 | 20,849 |
| Net Cash Flow | $24,515 | $29,098 | $-3,804 | $-15,945 | $-10,919 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,524 | -9,540 | -4,677 | -16,537 | -11,421 |
| Capital Expenditure | -198 | -37 | -6 | -122 | -114 |
| Free Cash Flow | -14,722 | -9,577 | -4,683 | -16,659 | -11,535 |